Sumitomo Pharma Co., Ltd.
https://www.sumitomo-pharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sumitomo Pharma Co., Ltd.
Sumitomo To Reprioritize Pipeline After Ulotaront’s Phase III Fail
Sumitomo Pharma is to focus more on late-stage candidates in oncology and cell/gene therapy while passing on full global rights for ulotaront and SEP-380135 to Otsuka.
Finance Watch: Mega-Rounds Around The World As VCs Spread The Wealth
Private Company Edition: After US-based Alumis and Sionna raised $259m and $182m, respectively, in series C rounds, Tubulis in Munich, Germany brought in €128m ($138.8m) in series B2 cash, while Rakuten – with offices in the US, Europe and Asia – closed a $119m series E round.
CGT Is In Its Infancy For CNS Disorders, But Technical Strides Being Made
Technical challenges and lackluster investor sentiment about the near-term commercial potential of cell and gene therapies in neurological disorders may be holding the field back.
Sumitomo Pharma To Cut 400 US Employees Amid Latuda LOE
After reducing 500 employees last year while reorganizing its subsidiaries in the US in the aftermath of patent expiration for its mainstay product Latuda, the Japanese firm has decided to move ahead with another rationalization affecting 400 employees there.
Company Information
- Industry
- Distributors
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Adagio Pharmaceuticals Ltd.
- Altavant Sciences
- Boston Biomedical, Inc.
- Boston Biomedical Pharma, Inc.
- Cannasat Therapeutics Inc.
- Cynapsus Therapeutics, Inc.
- Dainippon Sumitomo Pharma Co., Ltd.
- Dainippon Sumitomo Pharma Europe Ltd.
- DS Pharma Promo Co., Ltd,
- Elevation Pharmaceuticals, Inc.
- Enzyvant Therapeutics, Inc.
- Enzyvant Sciences, Ltd.
- Myovant Sciences Ltd
- Myovant Sciences GmbH
- Myovant Sciences, Inc.
- Oryx Pharmaceuticals Inc.
- SB Bioscience Co., Ltd.
- Spirovant Sciences
- Sumitomo Chemical Co., Ltd.
- Sumitomo Dainippon Pharma America, Inc. (formerly Dainippon Sumitomo Pharma America Holdings, Inc.)
- Sumitomo Dainippon Pharma Oncology, Inc.
- Sumitomo Pharmaceuticals America
- Sumitomo Pharmaceuticals (Suzhou) Co., Ltd.
- Sumitovant Biopharma
- Sunovion Pharmaceuticals Inc. (formerly Sepracor Inc.)
- Sunovion Pharmaceuticals Europe Ltd.
- Sunovion Respiratory Development Inc.
- Tolero Pharmaceuticals, Inc.
- Urovant Sciences, Inc.
- Sumitomo Pharmaceuticals Taiwan Co., Ltd.
- Sumitomo Dainippon Pharma Co., Ltd.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice